Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -11.43%42.31B | -13.16%26.19B | -18.71%12.11B | -3.45%64.37B | -4.70%47.77B | 1.03%30.16B | 13.29%14.9B | 13.03%66.67B | 18.00%50.12B | 17.43%29.85B |
| Refunds of taxes and levies | -19.83%341.2M | -6.57%258.72M | 485.52%201.09M | 159.33%447.91M | 192.90%425.58M | 118.92%276.91M | -63.68%34.34M | -92.91%172.72M | -92.32%145.3M | -92.89%126.49M |
| Net deposit increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Net increase in borrowings from central bank | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Net increase in placements from other financial institutions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash received from interests, fees and commissions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Net increase in repurchase business capital | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Premiums received from original insurance contracts | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Net cash received from reinsurance business | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Net increase in deposits from policyholders | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Net increase in funds disbursed | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Net cash received from trading securities | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash received relating to other operating activities | 24.92%688.23M | 18.58%473.61M | 29.38%162.14M | 15.18%389.41M | -9.43%550.94M | 71.58%399.41M | -54.04%125.33M | 28.68%338.09M | -26.79%608.3M | -11.84%232.79M |
| Cash inflows from operating activities | -11.09%43.34B | -12.69%26.92B | -17.16%12.47B | -2.94%65.21B | -4.19%48.74B | 2.06%30.83B | 11.39%15.06B | 8.92%67.18B | 12.56%50.88B | 10.00%30.21B |
| Goods services cash paid | -1.40%31.79B | -7.48%19.48B | -14.82%8.8B | -9.94%46.26B | -17.46%32.24B | -14.92%21.06B | -12.53%10.33B | -6.15%51.36B | 0.90%39.05B | -2.05%24.75B |
| Staff behalf paid | 5.05%2.08B | 3.91%1.38B | 3.51%722.98M | 7.46%3.22B | 8.45%1.98B | 11.35%1.33B | 10.61%698.48M | 9.38%2.99B | 11.48%1.83B | 9.77%1.2B |
| All taxes paid | -35.68%1.32B | -40.35%854.21M | -48.30%464.99M | 6.26%3.01B | 21.31%2.06B | 56.13%1.43B | 139.41%899.47M | 64.63%2.84B | 73.89%1.7B | 32.43%917.22M |
| Net loan and advance increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Net deposit in central bank and institutions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Net lend capital | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash paid for fees and commissions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash paid for indemnity of original insurance contract | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Policy dividend cash paid | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash paid relating to other operating activities | -15.27%1.35B | -16.02%841.82M | 19.11%483.81M | 14.15%1.74B | 26.04%1.6B | 61.32%1B | 2.00%406.19M | 50.35%1.53B | -3.31%1.27B | 0.79%621.35M |
| Cash outflows from operating activities | -3.51%36.55B | -9.11%22.56B | -15.11%10.47B | -7.64%54.23B | -13.62%37.88B | -9.69%24.83B | -6.66%12.34B | -2.47%58.72B | 2.85%43.85B | -0.66%27.49B |
| Net cash flows from operating activities | -37.52%6.79B | -27.47%4.36B | -26.49%2B | 29.64%10.98B | 54.59%10.87B | 120.79%6.01B | 810.25%2.72B | 472.06%8.47B | 173.62%7.03B | 1,405.62%2.72B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash received from returns on investments | -30.40%254.51M | -52.82%142.39M | --0 | 19.92%369.22M | 18.30%365.69M | 28.79%301.79M | 12,994.15%134.96M | 19.47%307.9M | 22.86%309.13M | -2.53%234.33M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -74.73%35.59M | -88.52%15.89M | -94.26%7.75M | 19.36%269.39M | 5,054.19%140.83M | -23.13%138.4M | 13,707.80%134.97M | -86.99%225.69M | -99.83%2.73M | -89.05%180.04M |
| Net cash received from disposal of subsidiaries and other business units | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash received relating to other investing activities | -45.63%217.74M | -74.71%101.23M | 75,338.79%41.26M | 302,571,760.82%4B | --400.48M | --400.21M | -93.47%54.7K | -100.00%1.32K | --0 | --0 |
| Cash inflows from investing activities | -44.01%507.83M | -69.12%259.51M | -81.85%49.01M | 769.32%4.64B | 190.83%907M | 102.82%840.4M | 9,388.92%269.98M | -74.14%533.59M | -83.59%311.86M | -78.02%414.37M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -11.15%8.42B | -3.52%5.93B | -13.05%3.17B | -30.18%15.16B | -36.54%9.48B | -37.25%6.14B | -23.78%3.65B | 48.74%21.72B | 87.73%14.94B | 120.26%9.79B |
| Cash paid to acquire investments | 536.82%327M | 537.16%327M | -46.31%27M | 704.43%436.8M | -91.86%51.35M | -86.72%51.32M | -75.50%50.29M | -82.27%54.3M | 9.84%630.96M | 11.44%386.49M |
| Net cash paid to acquire subsidiaries and other business units | --0 | --0 | --0 | -56.05%159.95M | --0 | --0 | --0 | 287.53%363.9M | --0 | --0 |
| Impawned loan net increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 |
| Cash paid relating to other investing activities | -94.67%13.53M | -94.41%12.5M | 191.53%924.72K | -31.52%3.14B | --253.79M | --223.7M | -50.71%317.19K | 2,022.26%4.58B | --0 | --0 |
| Cash outflows from investing activities | -10.44%8.76B | -2.36%6.27B | -13.49%3.2B | -29.27%18.9B | -37.15%9.78B | -36.93%6.42B | -25.92%3.7B | 75.58%26.72B | 44.54%15.57B | 112.38%10.18B |
| Net cash flows from investing activities | 7.01%-8.26B | -7.69%-6.01B | 8.10%-3.15B | 45.54%-14.26B | 41.81%-8.88B | 42.86%-5.58B | 31.29%-3.43B | -99.07%-26.18B | -71.99%-15.26B | -235.79%-9.77B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 936.85%877.02M | 153.63%142.87M | 294.44%71M | -79.11%988.02M | -20.03%84.59M | -46.86%56.33M | -64.37%18M | 913.11%4.73B | -69.58%105.77M | -20.59%105.99M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 936.85%877.02M | 153.63%142.87M | 294.44%71M | -79.11%988.02M | -20.03%84.59M | -46.86%56.33M | -64.37%18M | 913.11%4.73B | -69.58%105.77M | -20.59%105.99M |
| Cash from bonds issue | ---- | ---- | ---- | 100.04%8.4B | ---- | ---- | ---- | 601.84%4.2B | ---- | ---- |
| Cash from borrowing | -5.58%25.96B | -4.31%18.51B | 12.68%11.46B | -39.03%33.61B | -38.11%27.49B | -36.57%19.34B | -32.70%10.17B | 9.91%55.12B | 31.51%44.42B | 61.45%30.49B |
| Cash received relating to other financing activities | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --240.45M | --0 | --0 |
| Cash inflows from financing activities | -2.69%26.83B | -3.86%18.65B | 13.17%11.53B | -33.12%42.99B | -38.07%27.58B | -36.60%19.4B | -32.80%10.19B | 25.53%64.29B | 30.48%44.53B | 60.88%30.6B |
| Borrowing repayment | -16.89%20.49B | -18.43%14.26B | 2.25%8.45B | -12.82%35.37B | -16.15%24.65B | -15.88%17.48B | 3.44%8.26B | 33.50%40.57B | 38.76%29.4B | 71.56%20.78B |
| Dividend interest payment | -16.03%2.1B | -19.43%1.55B | -36.52%493.7M | 17.64%3.35B | 25.58%2.5B | 42.83%1.92B | 41.25%777.71M | 25.58%2.85B | 26.54%1.99B | 31.14%1.35B |
| -Including:Cash payments for dividends or profit to minority shareholders | -22.08%425.53M | -27.55%307.35M | -46.23%144.92M | 124.36%544.11M | 126.71%546.09M | 424.40%424.2M | 1,352.65%269.52M | 587.02%242.51M | 670.43%240.88M | 221.32%80.89M |
| Cash payments relating to other financing activities | 12.28%1B | 35.20%494.78M | 17.10%205.81M | -57.56%1.12B | -38.95%891.44M | -75.07%365.97M | 224.01%175.75M | -24.22%2.63B | 456.95%1.46B | 6,961.18%1.47B |
| Cash outflows from financing activities | -15.88%23.58B | -17.54%16.3B | -0.74%9.15B | -13.50%39.84B | -14.64%28.04B | -16.21%19.77B | 7.26%9.22B | 27.46%46.05B | 42.69%32.84B | 79.30%23.59B |
| Net cash flows from financing activities | 802.96%3.25B | 738.88%2.35B | 144.83%2.38B | -82.67%3.16B | -103.96%-462.26M | -105.25%-367.93M | -85.18%973.75M | 20.91%18.24B | 5.18%11.68B | 19.53%7.01B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 114.91%11.81K | 114.88%11.78K | 1,406.25%209 | -42,429.41%-79.16K | -25,399.68%-79.19K | -21,502.16%-79.19K | 93.07%-16 | -80.76%187 | -72.03%313 | -23.71%370 |
| Net increase in cash and cash equivalents | 16.88%1.78B | 1,086.48%698.24M | 363.31%1.23B | -123.57%-122.66M | -55.80%1.53B | 251.42%58.85M | -85.86%266.28M | -84.74%520.36M | -28.11%3.45B | -101.42%-38.87M |
| Add:Begin period cash and cash equivalents | -1.03%11.83B | -1.03%11.83B | -1.03%11.83B | 4.55%11.95B | 4.55%11.95B | 4.55%11.95B | 4.55%11.95B | 42.51%11.43B | 42.51%11.43B | 42.51%11.43B |
| End period cash equivalent | 1.00%13.62B | 4.30%12.53B | 6.91%13.07B | -1.03%11.83B | -9.45%13.48B | 5.42%12.01B | -8.23%12.22B | 4.55%11.95B | 16.06%14.89B | 5.83%11.39B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | PwC Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.